Home › Therapeutic areas › Metabolic › Type 1 Diabetes
Type 1 Diabetes (9 companies)
Companies with an active program in Type 1 Diabetes.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| IPSC | Century Therapeutics | ImmunologyMetabolic+1 Rare | 1 | Phase 1 | 9 |
| ELDN | Eledon Pharmaceuticals | ImmunologyMetabolic+1 Rare | 1 | Phase 2 | 3 |
| IMCR | Immunocore | DermatologyInfectious Disease+2 | 1 | Approved | 11 |
| KURA | Kura Oncology | MetabolicOncology | 1 | Approved | 12 |
| LCTX | Lineage Cell Therapeutics | MetabolicNeurology+1 Rare | 1 | Phase 2 | 12 |
| NKTR | Nektar Therapeutics | DermatologyImmunology+2 | 1 | Phase 3 | 11 |
| SABS | SAB Biotherapeutics | Metabolic | 1 | Phase 2 | 1 |
| SANA | Sana Biotechnology | MetabolicOncology | 2 | Phase 1 | 4 |
| VTVT | vTv Therapeutics | MetabolicRespiratory Rare | 2 | Phase 3 | 8 |
No companies match.